PURPOSE AND PROFIT: RESPONSIBLE INVESTMENT FOR A BETTER WORLD Brightwell Partners LLP (Brightwell) is a firm focused on opportunities where financial and social returns combine in a single proposition. Since its launch two years ago, Brightwell has been involved in over $2.2bn of fundraising, including Syncona, a collaboration between the Wellcome Trust, Cancer Research UK and the Battle Against Cancer Investment Trust to form a leading global investor in new medical technologies. Most recently Brightwell has worked on the Dementia Discovery Fund (DDF) alongside SV Health Investors, an international venture capital firm focused on biotech and life sciences more generally. The DDF is a unique collaboration between government, charity and big pharma and aims to develop disease modifying drugs for dementia more broadly, including Alzheimer’s. The DDF is one of the largest early stage single strategy venture capital funds ever raised. Brightwell’s core focus areas are in Sustainability, specifically on the creation of products and the raising of funds around the UN’s Sustainable Development Goals (SDGs). Brightwell also redirects a share of its revenues to charitable causes and impact initiatives.